Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACH7 TECHNOLOGIES LIMITED Investor Presentation 2023

Sep 27, 2023

65285_rns_2023-09-27_b0d207a6-b2ea-4654-bdb8-54bd50b33bbb.pdf

Investor Presentation

Open in viewer

Opens in your device viewer

ASX Announcement

==> picture [104 x 26] intentionally omitted <==

28 September 2023

MACH7 TECHNOLOGIES TO HOLD INVESTOR DAY

Mach7 Technologies Limited (“Mach7” or the “Company”) (ASX:M7T), a company specialising in innovative medical imaging software solutions advises that it will hold an Investor Day on Monday 9 October 2023 from 8.30-11.00am (AEDT) .

CEO and Managing Director Mike Lampron will be joined by other key executives for the briefing which will include a product demonstration.

Investors can register for the briefing via the following link:

https://mach7t.zoom.us/webinar/register/WN_EYnhMa0gQz2BKf7UMfJ8Yg

Investors will be able to ask questions via the Q&A function during the briefing.

A recording of the Investor Day will be available after the event on Mach7’s Investor Relations website (https://www.mach7t.com/about-us/investors).

Released on authority of the Board by: Mike Lampron Managing Director and Chief Executive Officer

For more information, please contact:

Françoise Dixon Head of Investor Relations Mach7 Technologies Limited +61 (0) 412 292 977 [email protected]

About Mach7 Technologies:

Mach7 Technologies (ASX:M7T) is a medical imaging systems provider that develops innovative image management and viewing solutions for healthcare organisations. The core of these offerings is the Mach7 Enterprise Imaging Solution, encompassing Enterprise Data Management, Enterprise Diagnostic Viewing and Diagnostic Workflow applications. Mach7’s Enterprise Data Management solution, consisting of a powerful Vendor Neutral Archive (VNA) and data administration tools, allows for the fast storage, access, retrieval and viewing of images across a healthcare network with connectivity to the Cloud. In July 2020, Mach7 acquired Client Outlook and the eUnity Enterprise Diagnostic Viewing technology to augment Mach7’s Enterprise Data Management and Diagnostic Workflow applications. eUnity is a zero-footprint, FDA-approved, image viewing solution that makes images accessible on any workstation. This offers healthcare professionals consolidated access to all patient images and data, ensuring clinical staff have timely access to the right information to diagnose and treat patients. Uniquely, the company also gives customers independence to deploy its solutions either on a component basis or in a unified comprehensive platform. Mach7 has built a global network of diverse customers that range from expansive Integrated Delivery Networks, National Health Systems, medical research facilities, and large academic medical institutions to regional community hospitals, private radiology practices, and independent provider groups. Visit Mach7t.com.

==> picture [150 x 53] intentionally omitted <==

Mach7 Technologies Limited (ASX:M7T) ABN: 26 007 817 192 Registered Office: Level 4, 96 – 100 Albert Road, South Melbourne, VIC 3205 T: +61 3 9692 7222 www.mach7t.com